Emergent Respiratory
Emergent Respiratory manufactures innovative medical devices for non-invasive ventilation therapy and dyspnea treatment.
Founded
2000Emergent Respiratory manufactures innovative medical devices for non-invasive ventilation therapy and dyspnea treatment.
Founded with a mission to revolutionize respiratory care, Emergent Respiratory focuses on developing innovative medical devices for non-invasive ventilation therapy. The company's core product, the Porto2vent (also known as CPAPos), is a fully pneumatic, closed-circuit ventilator designed to deliver continuous positive airway pressure (CPAP) to spontaneously breathing patients. This device, along with their proprietary S3 Foam Mask and single-use breathing circuits, aims to provide early intervention for various forms of dyspnea, including congestive heart failure (CHF).
Emergent Respiratory has garnered attention from notable figures in the medical device industry and has secured investments from key healthcare-focused venture capital firms. Their FDA-approved Porto2vent has been recognized for its advanced patient demand-driven gas delivery system, which significantly improves patient outcomes. The company's impact is evident in its contribution to enhancing non-invasive ventilation therapy, providing critical support to patients with respiratory difficulties, and advancing the field of medical technology.
Companies similar to Emergent Respiratory include Invent Medical, CorVent Medical, Circadiance and Compact Medical.
Emergent Respiratory was founded in 2000.
Emergent Respiratory's headquarters is located in Carlsbad, CA, US.
Emergent Respiratory's most recent funding round was for $5.3M (USD) in December 2003.
As of Dec 15, 2003, Emergent Respiratory has disclosed funding of $5.3M (USD). Undisclosed round amounts are excluded.
Emergent Respiratory has 4 employees as of Feb 4, 2024.
Compact Medical
